This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.

Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.

Abstracts will be reviewed by a committee of experts; accepted abstracts will be selected for either an oral or poster presentation. Please note that the deadline for abstract submissions is August 21, 2017.   Late abstracts will not be accepted.

Registration is free and highly encouraged due to limited space.  Online registration will close October 3, 2017.  If you register and are unable to attend contact Susan Kerin (susank@capconcorp.com) in order to have an accurate count.

You may visit the website here.